Rebusquillo, Fortunato P.
HRN: 23-35-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2025
CEFTRIAXONE 1G (VIAL)
06/12/2025
06/19/2025
IV
1g
Q12
Indirect Inguinal Hernia Left Reducible
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes